Drug Evaluation: Chimerivax-West Nile Vaccine
CURRENT OPINION IN MOLECULAR THERAPEUTICS(2007)
摘要
Acambis (formerly Peptide Therapeutics) is developing ChimeriVaxWest Nile, a recombinant live-attenuated vaccine which incorporates their ChimeriVax platform technology, for the potential prevention of West Nile virus infection [ 373463], [ 328969]. A phase II clinical trial to assess the safety, tolerability and immunogenicity of different doses of ChimeriVax-West Nile is underway [642090], [775386].
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络